Searchable abstracts of presentations at key conferences in endocrinology

ea0063p908 | Diabetes, Obesity and Metabolism 3 | ECE2019

Association of dipeptidyl peptidase 4 inhibitor use with risk of bullous pemphighoid

Damas-Fuentes Miguel , Gomez-Perez Ana , Munoz-Garach Araceli , Mancha-Doblas Isabel , Tinahones-Madueno Francisco

Introduction: Recent studies suggest that the use of dipeptidyl peptidase 4 inhibitors (DPP-4i) may be associated with an increased risk of developing bullous pemphigoid; which has led to publication of several pharmacovigilance alerts.Objectives: To characterize the potential association between the use of DPP-4i and the risk of developing bullous pemphigoid.Material & methods: Observational, retrospective study based on clini...

ea0041ep481 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Influence of obesity and carbohydrate metabolism disorders in GLP-1 levels in women with history of gestational diabetes mellitus

Maraver-Selfa Silvia , Jose Picon-Cesar Maria , Molina-Vega Maria , Mancha-Doblas Isabel , Tinahones-Madueno Francisco

Introduction: There is a reduction of the incretin effect in patients with type 2 diabetes secondary to altered secretion of incretin hormones and/or failed of its action.Objective: To study the GLP-1 secretion pattern after an oral glucose tolerance test (OGTT) in postpartum reassessment of women with previous GDM.Materials and methods: Prospective epidemiological study of 48 women with a history of GDM. We evaluated age, history ...

ea0081p454 | Reproductive and Developmental Endocrinology | ECE2022

Different grade of obesity influences the association between 25-hydroxyvitamin and Testosterone levels: A cross-sectional study in young Spanish men with Obesity

Boughanem Hatim , Damas-Fuentes Miguel , Vega Maria Molina , Jose Tinahones Madueno Francisco , Carlos Fernandez Garcia Jose , Macias Manuel

Backgrounds: One of the most observations in subjects with obesity, is a high prevalence of vitamin D deficiency, which, in turn, it has been implicated with decreased testosterone levels and an increased hypogonadism risk. Testosterone deficiency is a very common feature in males with obesity. However, only few studies have investigated the effect of vitamin D on testosterone in the context of obesity, and controversial results has been found.Hypothesis...

ea0081ep315 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Analysis of glycemic control in type 1 diabetes patients using flash glucose monitoring

Damas-Fuentes Miguel , Martinez Montoro Jose Ignacio , Simon Frapolli Victor , Fernadez Valero Andrea , Tinahones Madueno Francisco Jose

Introduction: Flash glucose monitoring expansion to an increasing number of patients with type 1 diabetes, coupled with its increased accuracy and ease of use, has increased available data on glycemic control in this population and allows detection of improvement areas in diabetes education and treatment.Objective: To analyze main parameters standardized by ATTD consensus (2019) in our population of patients with type 1 diabetes using flash glucose monit...

ea0037gp.11.06 | Calcium, Vitamin D and Bone (1) | ECE2015

Relationship between serum 25-hydroxivitamin D3 and adipose tissue vitamin D receptor gene expression with obesity and type 2 diabetes

Munoz-Garach Araceli , Clemente-Postigo Mercedes , Fernandez-Garcia Diego , Cardona-Diaz Fernando , Macias-Gonzalez Manuel , Tinahones-Madueno Francisco

Introduction: 25-hydroxyvitamin D (25(OH)D3) deficiency has been associated with diabetes and obesity. However, the mechanisms underlying these relationships are not completely understood. Vitamin D receptor (VDR) is expressed in adipose tissue; it has been reported a higher expression in obese patients than in lean subjects, suggesting a differential vitamin D dynamics in adipose tissue according to the obesity degree. In addition, 1, 25-dihydroxyvitamin D3 (1,25(OH)2D3) is a...

ea0056p362 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Is it useful the O’Sullivan test ≥200 to diagnose gestational diabetes mellitus (GDM)?

Molina-Vega Maria , Picon-Cesar Maria Jose , Hernandez-Garcia Carmen , Damas-Fuentes Miguel , Diaz-Perdigones Cristina , Tinahones-Madueno Francisco

Introduction: A two-step approach is usually used to diagnose GDM. At 24–28 weeks of pregnancy, a 50 g 1-hour glucose or O’Sullivan test is performed. If it is positive (≥140 mg/dl), it is followed by a 100 g-3 hours-Oral Glucose Tolerance Test (OGTT) which is considered positive if at least two or more values are ≥ of reference values (105-190-165-145 mg/dl). Despite it is not include in any clinical practice guideline, sometimes the 100 g OGTT is obviat...

ea0081p368 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Comparative analysis of clinical, obstetric and perinatal characteristics of pregnant women according to serum levels of vitamin D

Simon Frapolli Victor Josa , Fernandez Valero Andrea , Fuentes Miguel Damas , Molina Vega Maria , Picon Casar Maria Josa , Tinahones Madueno Francisco Josa

Introduction: Vitamin D is considered a fat-soluble vitamin and a fundamental prohormone in mineral and bone metabolism, with an immunoregulatory, cardiovascular and neuroprotective effect, among others. Vitamin D can be found as vitamin D2 or ergocalciferol and vitamin D3 or cholecalciferol. The main source of vitamin D comes from ultraviolet radiation in sunlight, but it is also obtained through food. Vitamin D deficiency is very prevalent in Europe, with a significant peak ...

ea0081ep252 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Comparative analysis of characteristics of pregnant women with pathological oral glucose tolerance test vs negative oral glucose tolerance test in a trimester of 2019

Simon Frapolli Victor Jose , Ignacio Martinez Montoro Jose , Picon Cesar Maria Jose , Gutierrez Repiso Carolina , Suarez Arana Maria , Tinahones Madueno Francisco Jose , Molina Vega Maria

Introduction: Gestational diabetes mellitus (GDM) is the metabolic disorder most frequently associated with pregnancy, presenting important maternal and fetal implications. Strict glycemic control through lifestyle measures and/or pharmacotherapy is essential to achieve adequate obstetric-perinatal results. The objective of this study is to compare baseline characteristics and perinatal results in patients diagnosed with GDM after performing oral glucose tolerance test (OGTT) ...

ea0090ep256 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Influence of diabetes mellitus on changes in preperitoneal fat measured by nutritional ultrasound, in a cohort of patients who required intensive care unit (ICU) admittance due to severe covid-19 pneumonia, during a 6-month follow-up program

Simon Frapolli Victor Jose , Aguilar Isabel Vegas , Rosa Victoria Gonzalez , Sanchez Garcia Ana Maria , Tinahones Madueno Francisco Jose , Garcia Almeida Jose Manuel

Introduction and Objectives: Preperitoneal fat is an ectopic visceral adipose tissue with a significant proinflammatory metabolic impact. The objective of this study is to measure preperitoneal fat by nutritional ultrasound at discharge, 3 months and 6 months in a cohort of patients who required admission to the Intensive Care Unit (ICU) due to severe COVID-19 pneumonia, and to analyze the differences based on the presence or not of previous DM.Material ...

ea0063p622 | Diabetes, Obesity and Metabolism 2 | ECE2019

Assessment of materno-fetal complications in pregnant women with type 1 diabetes exposed to insulin degludec

Martinez Montoro Jose Ignacio , Hernandez Garcia Carmen , Jose Picon Cesar Maria , Molina Vega Maria , Maria Diaz Perdigones Cristina , Damas Fuentes Miguel , Jose Tinahones Madueno Francisco

Introduction: Pregnancy in women with type 1 diabetes mellitus (T1DM) is associated with an increased risk of adverse outcomes, so pregnancy planning in order to achieve an optimal glycemic control is essential. This control has been made possible, in part, by the widespread use of insulin analogues, especially the long-acting ones, glargine and detemir. Insulin degludec, an ultra-long-acting insulin is not currently approved for pregnant women due to the lack of randomized co...